UNSPSC 51381512: Meclofenamic acid

This classification denotes a cyclooxygenase inhibitor and veterinary nonsteroidal anti inflammatory drug with the molecular formula C14H11Cl2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 48I5LU4ZWD, chemically known as 2-(2, 6-dichloro-3-methylphenyl)aminobenzoic acid but generally known as meclofenamic acid, which bears US NIH Compound Identifier 4037. European Medicines Agency schedules Meclofenamic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08678MIG.

UNSPSC 51381512 Meclofenamic acid is a Commodity code, but the recent state and local procurement activity tagged under it does not align with the code's nominal scope. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, to procure naloxone and safe drug deactivation systems—pharmaceutical and medical-device products that fall outside the meclofenamic acid category. The code shows little relevant recent activity for the pharmaceutical anti-inflammatory specified in its name.

The sole identified opportunity reflects a public health acquisition rather than procurement activity aligned with meclofenamic acid. Seminole County's IFB sought 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the county community health building in Sanford, Florida, and a response deadline of July 26, 2023. The contract included a two-year initial term with one-year renewal option, E-Verify compliance and drug-free workplace certification requirements, and potential FEMA funding with associated federal regulatory obligations. Without additional recent opportunities tied directly to meclofenamic acid procurement by state and local governments, the code does not surface actionable sourcing patterns for business development at this time.